Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_32_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
22 Мб
Скачать
292 Genitourinary Malignancies
https://t.me/medicina_free
Table 21.5 Stage summary for rhabdomyosarcoma
Stage Site Size Node status Metastasis
1 Favorable site Any N0 or N1 M0 2 Unfavorable site Tumor 5 cm N0 M0 3 Unfavorable site Tumor 5 cm N1 M0 3 Unfavorable site Tumor >5 cm N0 or N1 M0 4 Any Any Any M1
N0, no positive nodes; N1, nodes positive; M0, no metastatic disease; M1, metastatic disease.
Stratication and Staging
e staging, grouping, and risk stratication of RMS relies on a complex algorithm based on key information on the patient’s history and tumor biology. e basics are summarized as follows:
Stage: Preoperative determination based on tumor size, location, and clinical node and metastatic status. Of note, bladder/prostate RMS can never be stage 1 because of its unfa­vorable location (Table 21.5).
Group: Postoperative classication based on completeness of surgical resec­tion. e assigned group is not static and can be altered prior to the initiation of chemotherapy.
Risk group: is is based on a combination of stage, group, patient age, histology, and fusion status. Risk groups are routinely revised and updated and are used to guide decisions on therapy, to stratify patients in clinical tri­als, and to counsel parents and patients on prognosis.
Bladder/Prostate Rhabdomyosarcoma
Initial evaluation
e evaluation for a new or suspected bladder/ prostate RMS is based on the medical history and physical examination followed by a renal and bladder ultrasound (Figure 21.6A). Information on the age of the child, presence or absence of voiding problems, including gross hematuria or symptoms of outlet obstruction and a possible his­tory of bladder augmentation may help to identify
risk factors for less common bladder masses. Basic laboratory biochemical and hematological studies should include a comprehensive metabolic panel, complete blood count, and coagulation panel. Early management of bladder/prostate RMS involves complex decision-making which should be the responsibility of a multi-disciplinary team. ese patients will then require complete staging with CT chest, CT/MRI of the abdomen and pel­vis, positron emission tomography (PET) CT, and bone marrow biopsies (Figure 21.6B, C).
Treatment
Surgery
Chemotherapy
Radiation
Historically bladder/prostate RMS was initially managed with radical cystoprostatectomy but this approach is now used in less than 10% of cases. e initial diagnosis is most commonly conrmed by endoscopic biopsy. is is then followed by an assessment of the feasibility of an organ-sparing surgical resection. Since most BP RMS are not amenable to complete resection at the time of diagnosis, initial treatment consists of chemotherapy – typically comprising vin­cristine, actinomycin, and cyclophosphamide (VAC). Numerous alternative chemotherapeu­tic agents have been evaluated but none have so far been shown to oer superior survival to VAC – which is approximately 80%. Radiation therapy is used primarily for local disease con­trol in cases where the primary tumor is not completely removed. e concept of “pre-treat­ment re-excision” refers to cases where aer the initial biopsy, the tumor is re-excised before
Rhabdomyosarcoma / Bladder/Prostate Rhabdomyosarcoma 293
https://t.me/medicina_free
Figure 21.6 (A) Bladder ultrasound obtained during the initial evaluation of a suspected pelvic
mass revealing a large, heterogeneous mass near the base of the bladder. (B) Sagittal T2 weighted magnetic resonance imaging of a patient with a large bladder/prostate rhabdomyosarcoma, which has cranially displaced the Foley catheter. (C) Positron emission tomography (PET) computed tomography of the same patient demonstrating PET-avid retroperitoneal lymphadenopathy.
294 Genitourinary Malignancies
https://t.me/medicina_free
initiating chemotherapy. A number of regimens incorporating dierent timing of radiation, che­motherapy, and surgery have been described. It is important to note that residual tumor seen on follow-up imaging aer chemoradiation therapy may not be malignant tissue but may consist of cells, which have dierentiated into mature rhabdomyoblasts which do not require addi­tional treatment.
Paratesticular Rhabdomyosarcoma
Treatment
Primary surgery
Chemotherapy
Radiation
Paratesticular RMS, unlike bladder/prostate RMS, is designated as a favorable site and should therefore be initially managed by radical surgery whenever possible. is includes an ipsilateral radical inguinal orchiectomy with high ligation (at the internal inguinal ring) of the spermatic cord (Figure 21.7A, B). Upon conrmation of the diagnosis, patients with paratesticular RMS are treated with combination VAC chemotherapy. e decision to perform ipsilateral retroperito­neal lymph node dissection (RPLND) is based on the patient’s age and imaging ndings. In chil­dren under 10 years of age this is limited to those with suspicious lymph nodes on staging cross­sectional imaging. Regardless of the presence or absence of lymphadenopathy, ipsilateral retro­peritoneal lymph node dissection should be per­formed in all patients aged 10 and over because of the much higher incidence of occult lymph node involvement in this age range. Radiation therapy is reserved for patients with locally advanced dis­ease, those with conrmed lymph node involve­ment and those whose orchidectomy had been performed by a transcrotal approach
Vaginal/Uterine
Chemotherapy
Radiation
Surgery
Figure 21.7 (A) Paratesticular rhabdomyosar-
coma presenting as a solid scrotal swelling. As in adults, exploration and orchidectomy should be performed via an inguinal approach and not by a scrotal incision. (B) Specimen delivered through the inguinal incision prior to removal. Penrose drain and clamps proximal to the mass achieve vascular control of the spermatic cord.
Gynecological RMSs are also classied as a favor­able site and are usually managed with primary chemotherapy followed by radiation. Surgical intervention is typically limited to the initial diagnostic biopsy, which is then followed by com­plete staging. Chemotherapy alone is curative in less than 50% of patients but with the addition of radiation therapy, the 5-year survival increases to over 80%. Brachytherapy oers similar survival outcomes to external beam radiation therapy but with fewer short and long-term radiation side eects.
Pre-pubertal primary testicular tumors / Initial Evaluation 295
https://t.me/medicina_free
PRE-PUBERTAL PRIMARY TESTICULAR TUMORS
Introduction
Primary testicular tumors comprise approxi­mately 1–2% of all solid tumors in prepubertal children. Although they aect 1 in 100,000 male children, up to 75% of these tumors have little or no malignant potential. e peak age of diagno­sis is around 2–4 years of age with a second peak in young adults. Common risk factors include; a previous history of undescended testis, a family history of testicular cancer, and a co-existing dis­order of sex development (DSD) particularly one that involves the Y- chromosome.
Initial Evaluation
Key points of the history and physical examina­tion include whether the mass is symptomatic (a painless mass is of greater concern), and pubertal status. Scrotal ultrasound is the initial imaging of choice (Figure 21.8). Careful attention should
be made to the appearance of the lesion on ultra­sound, its location within or adjacent to the testis (i.e. whether it is a paratesticular mass or a pri­mary testicular mass), and the appearances of contralateral testis. Multifocal tumors are more indicative of malignancy.
Laboratory evaluation should always include
the standard serum tumor markers (STM) for tes­ticular tumors, including alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (β-hCG), and lactate dehydrogenase (LDH). However, AFP may not be a reliable tumor market in the rst 8 months of life because of a physiological eleva­tion of AFP occurring in this age range. If there is suspicion that the lesion may represent a stromal­type tumor, additional hormonal evaluation is indicated, including serum testosterone, estradiol, and inhibin levels. e dierential diagnosis for a newly discovered testicular mass is summarized in Table 21.6.
Because of the relatively low incidence of met-
astatic disease associated with testicular tumors in children, further evaluation with CT should be used selectively. In asymptomatic children
Figure 21.8 Testicular ultrasound demonstrating a heterogeneous intratesticular mass suspicious
for a primary testicular malignancy.
296 Genitourinary Malignancies
https://t.me/medicina_free
Table 21.6 Differential diagnosis for a newly
discovered testicular mass
Tumor Associations
Germ cell tumor Teratoma and yolk-sac
most common Stromal tumors Precocious puberty Epidermoid cyst Concentric rings on
ultrasound Metastatic lesion Lymphoma Gonadoblastoma Malignant precursor and
DSD
DSD, difference in sex development.
presenting with a primary testicular tumor it can be deferred until aer surgery has been per­formed and the results of the nal pathology evaluation are available. However, a preopera­tive CT scan to assess the total tumor burden is indicated in children with marked elevation of standard tumor markers or clinical evidence of metastatic disease.
Staging
e staging employed by the children’s oncology group diers from the one used for staging tes­ticular tumors in adults (Table 21.7). is reects the fact that the majority of prepubertal tumors are benign and are conned to the testis. Aer puberty, however, the staging is the same as for adults with testicular tumors.
Treatment
Surgery
Chemotherapy
Radiation
Table 21.7 Children’s oncology group pediatric
testicular tumor staging
Stage Description
I Limited to testis, completely resected
No evidence of disease beyond testis
STM normal
II Microscopic residual disease
Elevated STM
Tumor rupture or scrotal biopsy prior
to orchiectomy
III Retroperitoneal lymph node
involvement
IV Distant metastasis
a
Lymph nodes >4 cm meet imaging criteria, lymph
nodes 2–4 cm need pathologic conrmation (i.e. biopsy), and lymph nodes 1–2 cm have unclear sig­nicance and may require additional evaluation prior to completing staging.
a
or neurological involvement. An inguinal incision should always be used for surgical exploration of a primary testicular tumor in a pre-pubertal boy because of the possible need to proceed to radi­cal orchiectomy. If the diagnosis is uncertain and preoperative tumor markers are normal, par­ticularly in patients with small (<2 cm), unifocal tumors, partial orchiectomy with intraoperative frozen section is a reasonable approach. In these cases, the use of intraoperative ultrasound can be helpful in locating the margins of the tumor prior to excision. If the frozen section raises sus­picion of malignancy the surgeon can proceed to perform a radical orchiectomy, whereas if the pathology is more consistent with a benign pro­cess, the aected testis can be spared. e possible requirement for further treatment (surgery, che­motherapy, or radiation therapy) is determined by the pathology and tumor characteristics.
Germ Cell Tumors
e initial treatment of testicular tumors in chil­dren usually consists of either radical or partial orchiectomy. Preoperative chemotherapy is lim­ited to children in whom a delay in starting che­motherapy could be life threatening because they have a large burden of disea se with pul monary and/
Teratoma
Teratomas are the most common benign testicu­lar tumor in prepubertal children. ey consist of a combination of the three germ-cell layers: endo­derm, ectoderm, and mesoderm. Epidermoid
Pre-pubertal primary testicular tumors / Stromal Tumors 297
https://t.me/medicina_free
cysts are considered part of this spectrum of tumors but contain only a single germ-cell layer and have the classic appearance of concentric hyperechoic rings on ultrasound. Teratomas are not usually accompanied by elevated serum tumor markers. e denitive treatment is orchi­ectomy (either radical or partial) performed via an inguinal incision.
Yolk-Sac tumor
Yolk-sac tumors (YST) are the most common malignant testicular tumors in children. ey are almost universally associated with elevated levels of AFP and are characterized by the histologic nding of Schiller-Duval bodies on microscopy. Ninety percent of YSTs present as Stage I disease and are managed by radical orchiectomy fol­lowed by monitoring serum AFP levels and chest and abdominal imaging at increasing intervals. Patients who present with stage II–IV disease (or stage I patients who experience a recurrence aer orchiectomy) are treated with bleomycin, etoposide, and cisplatin chemotherapy. In addi­tion, patients with retroperitoneal lymph node involvement should undergo formal radical lymph node dissection.
Stromal Tumors
Leydig and Sertoli cell tumors
Leydig cell tumors (LCT) are the most common stromal tumor in childhood and are oen associ­ated with elevations in serum testosterone, which can lead to precocious puberty. Histologically they are dened by the presence of Reinke crys­tals, which are pathognomonic for LCTs. In pre­pubertal patients these tumors are universally benign and complete surgical excision is consid­ered curative. Sertoli cell tumors (SCT), are the second most common testicular stromal tumor and may be may be associated with gynecomas­tia in the postpubertal age range. ey are benign tumors with no reported cases of metastasis in children. A variant of Sertoli cell tumor can occur in patients with Peutz-Jeghers syndrome. Because they are benign tumors, Leydig and Sertoli cell tumors in children can be managed initially by
testicular sparing surgery (partial orchiectomy) with intraoperative frozen section.
Juvenile granulosa cell tumors
Juvenile granulosa cell tumors (JGCT) are almost exclusively seen in the rst year of life and can even be present at birth. ese tumors are hor­monally inactive, benign tumors that are oen associated with Y-chromosomal abnormalities. In addition to surgical excision, a karyotype should be performed to rule out a concomitant genetic disorder.
KEY POINTS
Molecular proling is likely to play a key role in risk-stratication and the design of targeted therapy for children with renal tumors and genitourinary rhabdomyosarcoma.
e overall survival of children with genitourinary malignancies is improv­ing dramatically as a result of the introduction of multimodal treatment (surgery, chemotherapy, and radia­tion therapy). e current challenge is to reduce the burden of treatment – related morbidity without compromis­ing survival rates.
Prepubertal testicular tumors are not usually as aggressive as testicular tumors in adults. Most cases can be managed with surgery and observation alone.
FURTHER READING
Saltzman, A.F., Cost, N.G., 2018. Childhood kid-
ney tumors. American Urological Association Update Series 37, 187–195.
Husmann, D.A., 2019. Cancer screening in the
pediatric cancer patient: a focus on genito­urinary malignancies, and why does a urolo­gist need to know about this? Journal of Pediatric Urology 15, 5–11.
298 Genitourinary Malignancies
https://t.me/medicina_free
Gooskens SL, Houwing ME, Vujanic GM, Dome
JS, Diertens T, Coulomb l’Herminé A, et al,
2017. Congenital mesoblastic nephroma 50 years after its recognition: a narrative review. Pediatric Blood & Cancer 64, e26437.
Malempati, S., Hawkins, D.S., 2012.
Rhabdomyosarcoma: review of the children’s oncology group (cog) soft-tissue sarcoma
committee experience and rationale for cur­rent COG studies. Pediatric Blood & Cancer 59, 5 –10.
Ross, J.H., Kay, R., 2004. Prepubertal testis
tumors. Rev Urol 6, 11–18.
Pediatric Genitourinary Trauma
https://t.me/medicina_free
DAVID J CHALMERS
Topics covered
22
General evaluation Renal trauma Ureteric injuries
INTRODUCTION
Trauma is the leading cause of mortality in children and young people. Management principles generally mirror those of adult trauma, which has the benet of more evidence-based guidelines. However, there are some key dierences. Renal injury is most fre­quently caused by blunt force – oen in conjunction with multisystem organ trauma. With some impor­tant exceptions, all but the most severe renal injuries are generally managed non-operatively. Ureteral injuries can occur from penetrating trauma or iat­rogenic injury during surgery in the retroperito­neum or pelvis. Bladder and urethral injuries are usually associated with other severe injuries involv­ing pelvic fractures and carry the greatest potential risk of long-term morbidity. Isolated external geni­tal trauma, depending on the history, should always trigger suspicion of possible sexual abuse. While pediatric urologists rarely have prime responsibility for the evaluation and treatment of pediatric trauma patients, they are relied upon heavily as consultants.
Bladder injuries Urethral injuries Injuries to the external genitalia
GENERAL EVALUATION
History
Evaluation begins by obtaining a comprehensive history from the patient, family or consulting clinician, followed by a physical examination if possible. Information should be sought on the mechanism of injury, associated injuries and any signicant comorbidities. It is important to enquire about the presence of hematuria and to look for evidence of abdominal or ank tender­ness, rib fractures, and contusions or abrasions to the abdomen, pelvis, or ank. Penetrating injuries to the torso, multisystem trauma and signicant hematuria always warrant further investigation. It is important to note, however, that genitouri­nary injuries associated with multisystem trauma are not always accompanied by hematuria. For this reason, the absence of hematuria should not preclude further investigation if other indications are present.
299
300 Pediatric Genitourinary Trauma
https://t.me/medicina_free
Physical Examination
Hemodynamic parameters are not reliable indi­cators of acute shock in children. Tachycardia may be a response to pain or anxiety and the cardiovascular system in children is capable of compensating more eectively for signi­cant blood loss through vasoconstriction and increased cardiac output. Signs of acute blood loss, anemia, and/or hypovolemia are indicators of advanced hemodynamic instability and even if the other vital signs are reassuring the clini­cian should nevertheless proceed with further evaluation and decisions on management. e physical examination should focus on the abdo­men and genitalia. A ank mass or ecchymosis suggests perinephric hematoma – which may also be associated with urinary extravasation. Ecchymosis of the perineum in a buttery pat­tern is suggestive of blood tracking within Colles Fasica while scrotal or labial hematoma can result from genital trauma or pelvic injury. e presence of blood at the urethral meatus or uri­nary retention should raise suspicion of urethral injury or disruption.
Figure 22.1 Grade 4 renal injury in a kidney
with previously undiagnosed ureteropelvic junction obstruction. This occurred following a fall from playground monkey bars. There were no other injuries and the injury failed to improve with conservative management. Ultimately, a nephrectomy was performed.
RENAL TRAUMA
e kidney is the commonest site of injury in the genitourinary system. e majority of renal inju­ries result from blunt trauma and approximately 80% are accompanied by injuries to other organs. Males outnumber females by almost 2:1, with the commonest causes being motor vehicle collisions, trac accidents and falls. Contact sports are an uncommon cause of serious renal injury in this age group.
It is thought that the kidney is more suscep­tible to blunt trauma in children than adults because it is proportionately larger and is less well protected by the ribs. Children also have less retroperitoneal fat and less musculature to buer and protect the kidneys. Horseshoe kidneys and hydronephrotic kidneys are at particularly high risk of injury even in the absence of associated organ injuries (Figure 22.1).
Evaluation and Investigations
Because hemodynamic signs are a less reliable guide to the severity of injury in children, greater reliance must be placed on the clinical history, physical examination, and the presence of associ­ated injuries.
e indications for radiographic evaluation
include;
Blunt trauma resulting from signicant decel­eration, such as a high-velocity motor vehicle collision or fall
Blunt trauma leading to other signicant multi-organ injuries
Penetrating injury to the abdomen or ank
Gross macroscopic hematuria or signicant microscopic hematuria
Haematuria is a much less reliable guide to the severity of renal trauma than in adults and >50% of children who have sustained a renal injury may not have hematuria at the time of presentation.
Renal trauma / Evaluation and Investigations 301
https://t.me/medicina_free
Ultrasound is a reasonable rst-line investiga­tion if the child is clinically stable and the his­tory and ndings on examination do not arouse concern. However, the accuracy of ultrasonog­raphy in detecting grade III renal lacerations is only 60% and is even lower in the detection of low grade renal injuries. Any evidence of renal injury detected by ultrasonography should then prompt a computerized tomography ( CT ) scan for a more detailed anatomical and functional assessment.
Contrast-enhanced CT with delayed imaging is the cornerstone of modern staging of blunt renal injuries. e A merican Associat ion for t he Su rgery of Trauma (AAST) organ injury scale for renal trauma (Figure 22.2) has been widely adopted to character­ize renal injuries and guide their management.
Grade I injuries are dened by decreased uptake of contrast material or subcapsular
hematoma. ey are essentially renal contusions and account for 80% of renal trauma cases.
Grade II and III injuries are tears in the renal
parenchyma. Tears <1 cm are considered grade II and >1 cm as grade III. ey are classied as minor if they are limited to the renal parenchyma and do not extend into the collecting system. Grade II and grade III injuries may be associated with extensive perinephric hematomas, but not urinary extravasation.
Grade IV injuries are lacerations, which also
involve the collecting system. Grade IV injury may also consist of damage to the hilar vessels – typically as a consequence of rapid deceleration causing shearing damage to the vessel wall, intra­mural haemorrhage, vascular occlusion, and clot formation. In such cases, renal perfusion in the injured kidney may be compromised even if the parenchyma remains intact.
Figure 22.2 American Association for the Surgery of Trauma (AAST) renal trauma classication.